OBI receives US FDA Orphan Drug Designation for OBI-992 TROP2 ADC for the treatment of gastric cancer

1. Date of occurrence of the event:2024/08/07 2. New drug name or code:OBI-992 TROP2 ADC 3. Indication: OBI-992 is an antibody drug conjugate (ADC) for cancer treatment that is based on TROP2 to target cancer cells. ADC releases a small molecule payload through the specificity of the antibody and directly deploys cytotoxic molecule at the […]